Amiodarone Washout Period
Due to amiodarone's exceptionally long elimination half-life of approximately 58 days, complete drug washout requires several months—typically 3-6 months—but attempting to achieve full washout before elective procedures is generally not recommended or practical. 1
Key Pharmacokinetic Considerations
Amiodarone's unique pharmacology makes traditional washout strategies impractical:
- Elimination half-life averages 58 days with significant individual variation 1
- The drug is highly lipid-soluble and accumulates in fat, muscle, liver, lungs, and skin with prolonged tissue retention
- Urinary iodine excretion remains elevated for a mean of 15.2 ± 7.7 months after discontinuation, confirming long-lasting total-body iodine stores 2
Clinical Approach by Procedure Type
For Cardiac Surgery
Amiodarone should NOT be routinely discontinued before cardiac surgery. 3 The risks of discontinuation outweigh the benefits:
- Delaying surgery by several weeks to months for washout exposes patients to increased risk of malignant dysrhythmias
- While complications occur (dysrhythmias in 52%, pacemaker requirement in 24%, vasoplegia), most can be symptomatically managed 3
- The alternative—uncontrolled arrhythmias during the waiting period—poses greater mortality risk
For Electrophysiology Procedures (Ablation)
A structured washout period of 5 half-lives is recommended to establish a drug-free baseline, though this must be balanced against arrhythmia risk 4:
- For diagnostic accuracy and procedural success, AAD washout is preferred
- Calculate washout based on patient-specific factors: age, renal function, hepatic impairment
- With amiodarone's 58-day half-life, complete washout would require approximately 290 days (9-10 months), which is clinically impractical 4
- Consider a pragmatic approach of 2-3 months washout when feasible, recognizing residual drug effects will persist
Notably, failure to maintain sinus rhythm on amiodarone before ablation does not predict ablation failure (success rates: 55.7% vs 60.5%, p=0.54), so amiodarone failure alone should not deter ablation 5
For Thyroid Function Assessment
Thyroid monitoring should continue for at least 15 months after amiodarone discontinuation due to persistent iodine excess 2:
- Iodine stores remain elevated throughout this period
- Thyroid dysfunction can develop at any time during or after treatment
- No correlation exists between urinary iodine levels and likelihood of developing thyroid dysfunction
For Radioactive Iodine Therapy
Extended washout is critical—plan for at least 6 months to allow sufficient reduction in total-body iodine stores 2:
- Elevated iodine levels will interfere with radioactive iodine uptake
- Consider measuring 24-hour urinary iodine to confirm adequate washout
- Normal range achievement typically requires 15+ months
Important Caveats
Drug interactions persist during washout:
- Warfarin interactions peak at 7 weeks but continue throughout washout 1
- Digoxin levels remain elevated due to ongoing P-glycoprotein inhibition 1
- Monitor INR weekly if on warfarin; reduce digoxin dose by 50% and monitor levels 1
The clinical reality: Complete amiodarone washout before most procedures is neither practical nor advisable. The decision must weigh:
- Urgency of the procedure
- Risk of arrhythmia recurrence during washout
- Specific requirements of the planned intervention
- Patient's overall clinical stability
For most elective non-EP procedures, proceed without attempting washout while optimizing perioperative monitoring and management of potential amiodarone-related complications.